1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on Artificial Pancreas Device System Industry 1.7 COVID-19 Impact: Artificial Pancreas Device System Market Trends 2 Global Artificial Pancreas Device System Quarterly Market Size Analysis 2.1 Artificial Pancreas Device System Business Impact Assessment - COVID-19 2.1.1 Global Artificial Pancreas Device System Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.1.2 Global Artificial Pancreas Device System Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global Artificial Pancreas Device System Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 Global Artificial Pancreas Device System Quarterly Market Size by Manufacturers, 2019 VS 2020 3.2 Global Artificial Pancreas Device System Factory Price by Manufacturers 3.3 Location of Key Manufacturers Artificial Pancreas Device System Manufacturing Factories and Area Served 3.4 Date of Key Manufacturers Enter into Artificial Pancreas Device System Market 3.5 Key Manufacturers Artificial Pancreas Device System Product Offered 3.6 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Artificial Pancreas Device System Segments, By Type 4.1 Introduction 1.4.1 Control-to-Range (CTR) System 1.4.2 Threshold Suspended Device System 1.4.3 Control - to - Target (CTT) System 4.2 By Type, Global Artificial Pancreas Device System Market Size, 2019-2021 4.2.1 By Type, Global Artificial Pancreas Device System Market Size by Type, 2020-2021 4.2.2 By Type, Global Artificial Pancreas Device System Price, 2020-2021 5 Impact of Covid-19 on Artificial Pancreas Device System Segments, By Application 5.1 Overview 5.5.1 Hospital 5.5.2 Clinic 5.5.3 Others 5.2 By Application, Global Artificial Pancreas Device System Market Size, 2019-2021 5.2.1 By Application, Global Artificial Pancreas Device System Market Size by Application, 2019-2021 5.2.2 By Application, Global Artificial Pancreas Device System Price, 2020-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 Medtronic 7.1.1 Medtronic Business Overview 7.1.2 Medtronic Artificial Pancreas Device System Quarterly Production and Revenue, 2020 7.1.3 Medtronic Artificial Pancreas Device System Product Introduction 7.1.4 Medtronic Response to COVID-19 and Related Developments 7.2 Johnson & Johnson 7.2.1 Johnson & Johnson Business Overview 7.2.2 Johnson & Johnson Artificial Pancreas Device System Quarterly Production and Revenue, 2020 7.2.3 Johnson & Johnson Artificial Pancreas Device System Product Introduction 7.2.4 Johnson & Johnson Response to COVID-19 and Related Developments 7.3 TypeZero Technologies 7.3.1 TypeZero Technologies Business Overview 7.3.2 TypeZero Technologies Artificial Pancreas Device System Quarterly Production and Revenue, 2020 7.3.3 TypeZero Technologies Artificial Pancreas Device System Product Introduction 7.3.4 TypeZero Technologies Response to COVID-19 and Related Developments 7.4 Tandem Diabetes 7.4.1 Tandem Diabetes Business Overview 7.4.2 Tandem Diabetes Artificial Pancreas Device System Quarterly Production and Revenue, 2020 7.4.3 Tandem Diabetes Artificial Pancreas Device System Product Introduction 7.4.4 Tandem Diabetes Response to COVID-19 and Related Developments 7.5 Pancreum 7.5.1 Pancreum Business Overview 7.5.2 Pancreum Artificial Pancreas Device System Quarterly Production and Revenue, 2020 7.5.3 Pancreum Artificial Pancreas Device System Product Introduction 7.5.4 Pancreum Response to COVID-19 and Related Developments 7.6 Insulet 7.6.1 Insulet Business Overview 7.6.2 Insulet Artificial Pancreas Device System Quarterly Production and Revenue, 2020 7.6.3 Insulet Artificial Pancreas Device System Product Introduction 7.6.4 Insulet Response to COVID-19 and Related Developments 7.7 Beta Bionics 7.7.1 Beta Bionics Business Overview 7.7.2 Beta Bionics Artificial Pancreas Device System Quarterly Production and Revenue, 2020 7.7.3 Beta Bionics Artificial Pancreas Device System Product Introduction 7.7.4 Beta Bionics Response to COVID-19 and Related Developments 7.8 Animas Corporation 7.8.1 Animas Corporation Business Overview 7.8.2 Animas Corporation Artificial Pancreas Device System Quarterly Production and Revenue, 2020 7.8.3 Animas Corporation Artificial Pancreas Device System Product Introduction 7.8.4 Animas Corporation Response to COVID-19 and Related Developments 7.9 LLC 7.9.1 LLC Business Overview 7.9.2 LLC Artificial Pancreas Device System Quarterly Production and Revenue, 2020 7.9.3 LLC Artificial Pancreas Device System Product Introduction 7.9.4 LLC Response to COVID-19 and Related Developments 7.10 Bigfoot Biomedical 7.10.1 Bigfoot Biomedical Business Overview 7.10.2 Bigfoot Biomedical Artificial Pancreas Device System Quarterly Production and Revenue, 2020 7.10.3 Bigfoot Biomedical Artificial Pancreas Device System Product Introduction 7.10.4 Bigfoot Biomedical Response to COVID-19 and Related Developments 8 Supply Chain and Sales Channels Analysis 8.1 Artificial Pancreas Device System Supply Chain Analysis 8.1.1 Artificial Pancreas Device System Supply Chain Analysis 8.1.2 Covid-19 Impact on Artificial Pancreas Device System Supply Chain 8.2 Distribution Channels Analysis 8.2.1 Artificial Pancreas Device System Distribution Channels 8.2.2 Covid-19 Impact on Artificial Pancreas Device System Distribution Channels 8.2.3 Artificial Pancreas Device System Distributors 8.3 Artificial Pancreas Device System Customers 9 Key Findings 10 Appendix 10.1 About Us 10.2 Disclaimer

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Artificial Pancreas Device System Assessment Table 9. COVID-19 Impact: Artificial Pancreas Device System Market Trends Table 10. COVID-19 Impact Global Artificial Pancreas Device System Market Size Table 11. Global Artificial Pancreas Device System Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units) Table 12. Global Artificial Pancreas Device System Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit) Table 13. Global Artificial Pancreas Device System Quarterly Market Size, 2020 (US$ Million) & (K Units) Table 14. Global Artificial Pancreas Device System Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 15. Global Artificial Pancreas Device System Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units) Table 16. Global Artificial Pancreas Device System Market Growth Drivers Table 17. Global Artificial Pancreas Device System Market Restraints Table 18. Global Artificial Pancreas Device System Market Opportunities Table 19. Global Artificial Pancreas Device System Market Challenges Table 20. Key Manufacturers Artificial Pancreas Device System Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 21. Top Manufacturers, Artificial Pancreas Device System Market Size, 2019 (K Units) & (US$ Million) Table 22. Artificial Pancreas Device System Factory Price by Manufacturers 2020 (USD/Unit) Table 23. Location of Key Manufacturers Artificial Pancreas Device System Manufacturing Plants Table 24. Key Manufacturers Artificial Pancreas Device System Market Served Table 25. Date of Key Manufacturers Enter into Artificial Pancreas Device System Market Table 26. Key Manufacturers Artificial Pancreas Device System Product Type Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Artificial Pancreas Device System Market Size by Type, 2020, (US$ Million) Table 29. Global Artificial Pancreas Device System Market Size by Type, 2020 (K Units) Table 30. Global Artificial Pancreas Device System Price: by Type, 2020-2021 (USD/Unit) Table 31. Global Artificial Pancreas Device System Market Size by Application: 2020-2021 (US$ Million) Table 32. Global Artificial Pancreas Device System Market Size by Application, 2020-2021 (K Units) Table 33. Global Artificial Pancreas Device System Price: by Application, 2020-2021 (USD/Unit) Table 34. Global Artificial Pancreas Device System Market Size by Region, 2019-2021 (US$ Million) Table 35. Global Artificial Pancreas Device System Market Size by Region, 2019-2021 (K Units) Table 36. By Country, North America Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) Table 37. By Country, North America Artificial Pancreas Device System Market Size, 2019-2021 (K Units) Table 38. US Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 39. Canada Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 41. By Country, Europe Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) Table 42. By Country, Europe Artificial Pancreas Device System Market Size, 2019-2021 (K Units) Table 43. Germany Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 44. France Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 45. UK Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 46. Italy Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 48. By Region, Asia-Pacific Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) Table 49. By Region, Asia-Pacific Artificial Pancreas Device System Market Size, 2019-2021 (K Units) Table 50. China Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 51. Japan Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 52. South Korea Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 53. India Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 54. ASEAN Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 55. Latin America Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 56. Middle East and Africa Artificial Pancreas Device System Market Size, 2019-2021 (US$ Million) & (K Units) Table 57. Medtronic Business Overview Table 58. Medtronic Artificial Pancreas Device System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. Medtronic Artificial Pancreas Device System Product Table 60. Medtronic Response to COVID-19 and Related Developments Table 61. Johnson & Johnson Business Overview Table 62. Johnson & Johnson Artificial Pancreas Device System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Johnson & Johnson Artificial Pancreas Device System Product Table 64. Johnson & Johnson Response to COVID-19 and Related Developments Table 65. TypeZero Technologies Business Overview Table 66. TypeZero Technologies Artificial Pancreas Device System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. TypeZero Technologies Artificial Pancreas Device System Product Table 68. TypeZero Technologies Response to COVID-19 and Related Developments Table 69. Tandem Diabetes Business Overview Table 70. Tandem Diabetes Artificial Pancreas Device System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. Tandem Diabetes Artificial Pancreas Device System Product Table 72. Tandem Diabetes Response to COVID-19 and Related Developments Table 73. Pancreum Business Overview Table 74. Pancreum Artificial Pancreas Device System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. Pancreum Artificial Pancreas Device System Product Table 76. Pancreum Response to COVID-19 and Related Developments Table 77. Insulet Business Overview Table 78. Insulet Artificial Pancreas Device System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. Insulet Artificial Pancreas Device System Product Table 80. Insulet Response to COVID-19 and Related Developments Table 81. Beta Bionics Business Overview Table 82. Beta Bionics Artificial Pancreas Device System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Beta Bionics Artificial Pancreas Device System Product Table 84. Beta Bionics Response to COVID-19 and Related Developments Table 85. Animas Corporation Business Overview Table 86. Animas Corporation Artificial Pancreas Device System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. Animas Corporation Artificial Pancreas Device System Product Table 88. Animas Corporation Response to COVID-19 and Related Developments Table 89. LLC Business Overview Table 90. LLC Artificial Pancreas Device System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. LLC Artificial Pancreas Device System Product Table 92. LLC Response to COVID-19 and Related Developments Table 93. Bigfoot Biomedical Business Overview Table 94. Bigfoot Biomedical Artificial Pancreas Device System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Bigfoot Biomedical Artificial Pancreas Device System Product Table 96. Bigfoot Biomedical Response to COVID-19 and Related Developments Table 97. Artificial Pancreas Device System Distributors List Table 98. Artificial Pancreas Device System Customers List Table 99. Covid-19 Impact on Artificial Pancreas Device System Customers List of Figures Figure 1. Artificial Pancreas Device System Product Picture Figure 2. Artificial Pancreas Device System Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Artificial Pancreas Device System Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Artificial Pancreas Device System Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Artificial Pancreas Device System Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Artificial Pancreas Device System Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Artificial Pancreas Device System Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Artificial Pancreas Device System Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Artificial Pancreas Device System Market Size Market Share, 2019-2021

Medtronic Johnson & Johnson TypeZero Technologies Tandem Diabetes Pancreum Insulet Beta Bionics Animas Corporation LLC Bigfoot Biomedical